|
|
||||||||

*
Department of Biochemistry and Molecular Biology, University of Illinois, Chicago, IL 60612; and
University of California, San Francisco Diabetes Center, Metabolic Research Unit/Hormone Research Institute, University of California, San Francisco, CA 94143
We have previously shown that exposure of P815 tumor cells to
melphalan (L-phenylalanine mustard;
L-PAM) leads to up-regulation of B7-1 surface
expression, and this L-PAM-induced up-regulation requires
de novo RNA synthesis and is associated with accumulation of B7-1 mRNA.
Here we show that the effect of L-PAM on B7-1 surface
expression can be mimicked by exposing P815 tumor cells to oxidative
stress but not to heat shock. Moreover, the antioxidant
N-acetyl-L-cysteine prevented the
L-PAM-induced accumulation of B7-1 mRNA in P815 tumor
cells, suggesting that reactive oxygen species are involved in the
transcriptional regulation of L-PAM-induced B7-1 gene
expression. Although AP-1 and NF-
B are regarded as redox-sensitive
transcription factors and the promoter/enhancer region of the B7-1 gene
contains an AP-1 and an NF-
B binding site, exposure of P815 tumor
cells to L-PAM led to rapid and transient activation only
of NF-
B, but not AP-1, that bound specifically to a probe containing
the respective binding site in the murine or human B7-1 gene. Moreover,
exposure of P815 tumor cells to a cell-permeable peptide that
selectively inhibits NF-
B activation by blocking the activation of
the I
B-kinase complex was found to inhibit the
L-PAM-induced B7-1 mRNA accumulation, indicating that
NF-
B activation is essential for the L-PAM-induced B7-1
gene expression. Taken together, these results indicate that
L-PAM leads to activation of B7-1 gene expression by
activating NF-
B via a pathway that involves reactive oxygen
species.
This article has been cited by other articles:
![]() |
M. Sharma, A. A. George, B. N. Singh, N. C. Sahoo, and K. V. S. Rao Regulation of Transcript Elongation through Cooperative and Ordered Recruitment of Cofactors J. Biol. Chem., July 20, 2007; 282(29): 20887 - 20896. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Rehman, S. Bertera, R. Bottino, A. N. Balamurugan, J. C. Mai, Z. Mi, M. Trucco, and P. D. Robbins Protection of Islets by in Situ Peptide-mediated Transduction of the Ikappa B Kinase Inhibitor Nemo-binding Domain Peptide J. Biol. Chem., March 7, 2003; 278(11): 9862 - 9868. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Sonis THE BIOLOGIC ROLE FOR NUCLEAR FACTOR-KAPPAB IN DISEASE AND ITS POTENTIAL INVOLVEMENT IN MUCOSAL INJURY ASSOCIATED WITH ANTI-NEOPLASTIC THERAPY Crit. Rev. Oral. Biol. Med., September 1, 2002; 13(5): 380 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D'Acquisto, M. J. May, and S. Ghosh Inhibition of Nuclear Factor Kappa B (NF-B):: An Emerging Theme in Anti-Inflammatory Therapies Mol. Interv., February 1, 2002; 2(1): 22 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Jovasevic and M. B. Mokyr Melphalan-Induced Expression of IFN-{beta} in MOPC-315 Tumor-Bearing Mice and Its Importance for the Up-Regulation of TNF-{alpha} Expression J. Immunol., November 1, 2001; 167(9): 4895 - 4901. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |